Substance / Medication

Amphotericin B cholesteryl sulphate complex

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

14 trials linked to this intervention

14
Total Trials
1
Recruiting
2
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Cryptococcosis in pregnancy and the postpartum period: Case series and systematic review with recommendations for management.
Pastick Katelyn A, Nalintya Elizabeth, Tugume Lillian et al. · Med Mycol · 2020
PMID: 31689712Meta-AnalysisFull text (PMC)
Endophthalmitis in patients co-infected by HIV and sporotrichosis: a systematic review of published case reports.
Ramírez-Soto Max Carlos, Bonifaz Alexandro, Tirado-Sánchez Andrés · Eye (Lond) · 2018
PMID: 29880916Meta-AnalysisFull text (PMC)
[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Salavert-Lletí Miguel, Zaragoza-Crespo Rafael · Rev Iberoam Micol · 2009
PMID: 19463284Meta-Analysis
Zygomycosis in children: a systematic review and analysis of reported cases.
Zaoutis Theoklis E, Roilides Emmanuel, Chiou Christine C et al. · Pediatr Infect Dis J · 2007
PMID: 17848885Meta-Analysis
Drugs for treating paracoccidioidomycosis.
Menezes V M, Soares B G O, Fontes C J F · Cochrane Database Syst Rev · 2006
PMID: 16625617Meta-AnalysisFull text (PMC)
Posaconazole as salvage therapy for zygomycosis.
Greenberg R N, Mullane K, van Burik J-A H et al. · Antimicrob Agents Chemother · 2006
PMID: 16377677RCTFull text (PMC)
Sources of microbial oils with emphasis to Mortierella (Umbelopsis) isabellina fungus.
Papanikolaou Seraphim, Aggelis George · World J Microbiol Biotechnol · 2019
PMID: 30923965Review
Human Pathogenic Entomophthorales.
Vilela Raquel, Mendoza Leonel · Clin Microbiol Rev · 2018
PMID: 30158298ReviewFull text (PMC)
Delay and misdiagnosis of basidiobolomycosis in tropical South India: case series and review of the literature.
Kumaravel S, Bharath Kumar, Rajesh N G et al. · Paediatr Int Child Health · 2016
PMID: 26825223Review
Entomophthoramycosis: a neglected tropical mycosis.
Shaikh N, Hussain K A, Petraitiene R et al. · Clin Microbiol Infect · 2016
PMID: 27109491Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Amphotericin B cholesteryl sulfate complex (substance)
SNOMED CT
427544000
UMLS CUI
C0338196

Clinical Data

This intervention maps to 17 entities in the Healos knowledge graph.

17
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
14
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.